通过血清分离的非哺乳动物AAVs进行完全中和抗体逃避,使基因疗法能够重新剂量
Ezra J Loeb1, Sophia A Fergione2, Vivian Yudistyra2
1Department of Biomedical Engineering, Duke University, Durham, NC, USA.
Cell reports. Medicine
|November 27, 2025
概括
研究人员设计了一种非灵长类动物来源的新型腺相关病毒 (AAV) 囊体,AAV.div3A,以克服先前存在的免疫力,并使患者能够重复基因治疗剂量.
科学领域:
- 基因治疗 基因治疗
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 对腺相关病毒 (AAV) 预先存在的免疫力限制了基因治疗的有效性.
- 来自灵长类动物的AAV表现出高血清流行率和抗原交叉活性,限制了患者的访问和再剂量.
- 对AAV载体的免疫反应可以防止成功的基因转移和治疗结果.
研究的目的:
- 为了设计新型的AAV囊体,逃避先前存在的和载体诱导的免疫力.
- 克服与免疫性相关的当前AAV基因疗法载体的局限性.
- 在基因疗法应用中实现有效的再剂量策略.
主要方法:
- 利用非哺乳动物依赖的病毒的基因多样性.
- 开发一个分离的Dependoparvovirus分离的条形码屏幕.
- 工程和表征仿真AAV囊,包括AAV.div3A和AAV.div3A-M1.
主要成果:
- 鉴定了AAV.div3A,一种具有零抗原交叉活性和无法检测的血清流行性的嵌合体体.
- 在小鼠中,AAV.div3A表现出强大的转导和完全逃避中和,即使具有先前存在的抗体.
- 经过工程设计的AAV.div3A-M1显示了增强的心脏和腹膜转导,在庞培病模型中成功重新剂量增加了治疗性酶水平.
结论:
- 利用非哺乳动物依赖的多样性是克服AAV免疫力的可行策略.
- 经过工程设计的AAV.div3A囊体扩大了患者对基因治疗的资格.
- 有效的再剂量可以通过新的,免疫学上不同的AAV载体实现,从而提高治疗潜力.
关键词:
腺相关病毒的病毒.卡普西德工程 工程这种病毒是 dependoparvovirus 的.基因治疗的基因疗法免疫逃避 免疫逃避中和抗体中和抗体.之前存在的免疫力.组织热带主义 组织热带主义载体重剂量是指载体的重剂量.更多相关视频
05:53A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
Published on: December 7, 2021
5.2K
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
5.1K
相关概念视频
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...